Amyloid Beta: Multiple Mechanisms of Toxicity and Only Some Protective Effects?
Open Access
- 5 February 2014
- journal article
- review article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2014, 1-15
Abstract
Amyloid beta (Aβ) is a peptide of 39–43 amino acids found in large amounts and forming deposits in the brain tissue of patients with Alzheimer’s disease (AD). For this reason, it has been implicated in the pathophysiology of damage observed in this type of dementia. However, the role of Aβin the pathophysiology of AD is not yet precisely understood. Aβhas been experimentally shown to have a wide range of toxic mechanismsin vivoandin vitro, such as excitotoxicity, mitochondrial alterations, synaptic dysfunction, altered calcium homeostasis, oxidative stress, and so forth. In contrast, Aβhas also shown some interesting neuroprotective and physiological properties under certain experimental conditions, suggesting that both physiological and pathological roles of Aβmay depend on several factors. In this paper, we reviewed both toxic and protective mechanisms of Aβto further explore what their potential roles could be in the pathophysiology of AD. The complete understanding of such apparently opposed effects will also be an important guide for the therapeutic efforts coming in the future.Keywords
This publication has 127 references indexed in Scilit:
- Amyloid-β fibrillogenesis: Structural insight and therapeutic interventionExperimental Neurology, 2010
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate UptakeNeuron, 2009
- Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's diseaseNeurochemistry International, 2009
- Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenalExperimental Neurology, 2008
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behaviorBehavioural Brain Research, 2008
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine, 2008
- Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairmentFree Radical Biology and Medicine, 2007
- An Update on the Amyloid HypothesisNeurologic Clinics, 2007
- Cell division in the CNS: Protective response or lethal event in post-mitotic neurons?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991